AstraZeneca reveals COVID-19 vaccine sales but that isn’t why the stock is rising
April 30, 2021 at 07:34 AM EDT
AstraZeneca stock jumped 3.4% in early trading on Friday, as the U.K.-Swedish drug company reported better-than-expected earnings, led by its blockbuster cancer drugs.